Skip to main content

Peer Review reports

From: The reimbursement for expensive medicines: stakeholder perspectives on the SMA medicine nusinersen and the Dutch Coverage Lock policy

Original Submission
7 Mar 2022 Submitted Original manuscript
29 Mar 2022 Reviewed Reviewer Report - Joost J. Enzing
7 Jun 2022 Reviewed Reviewer Report - Katharina Habimana
30 Jun 2022 Author responded Author comments - Féline E.V. Scheijmans
Resubmission - Version 2
30 Jun 2022 Submitted Manuscript version 2
19 Jul 2022 Author responded Author comments - Féline E.V. Scheijmans
Resubmission - Version 3
19 Jul 2022 Submitted Manuscript version 3
Publishing
25 Jul 2022 Editorially accepted
4 Nov 2022 Article published 10.1186/s12913-022-08690-z

You can find further information about peer review here.

Back to article page